JAZZ Dividend History & Analysis | N/A Yield
JAZZ has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Pharmaceuticals
| Symbol | Market Cap USD | Dividend Yield TTM | Yield on Cost 5y |
|---|---|---|---|
| SIGA | 449 M | 9.57% | 11.3% |
| NBY | 781 M | 13.6% | 0.14% |
| PFE | 141,574 M | 8.54% | 7.45% |
| PRGO | 1,912 M | 8.35% | 3.11% |
| SAN | 115,717 M | 4.76% | 6.05% |
| Symbol | Market Cap USD | Growth Rate (CAGR) | Payout Consistency |
|---|---|---|---|
| ZTS | 56,023 M | 18.9% | 100% |
| LLY | 963,404 M | 15.3% | 99.5% |
| BMY | 108,831 M | 14.0% | 92.6% |
| MRK | 62,392 M | 12.0% | 91.8% |
| SIGA | 449 M | 10.1% | 98.0% |
Similar Stocks with Attractive Dividends - Compare JAZZ Dividends with its Peer-Group
9.57% Yield
4.76% Yield
3.08% Yield
2.48% Yield
2.88% Yield
1.21% Yield
JAZZ Dividend History: as of January 2026
No dividends paid yet.JAZZ Dividend FAQ
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) is a Dublin-based specialty biopharma that develops and commercializes products across neurology, oncology, and hematology in the U.S., Europe, and other markets. Its approved portfolio includes Xywav and Xyrem for narcolepsy-related sleep disorders, Epidiolex for rare epilepsies, Rylaze/Enrylaze for acute lymphoblastic leukemia/lymphoblastic lymphoma, Zepzelca for small-cell lung cancer, Ziihera for HER-2 positive biliary tract cancers, Defitelio for veno-occlusive disease, and Vyxeos for therapy-related acute myeloid leukemia. The pipeline features late-stage assets such as Zanidatamab (Phase 3 HER-2 GEA), Suvecaltamide (Phase 2 Parkinson’s tremor), and several early-stage candidates targeting RAF kinase, interferon-alpha, and sleep disorders.
What is the Dividend Yield of JAZZ?
As of January 2026, JAZZ`s dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 173.15.Does JAZZ pay a dividend?
As of January 2026 JAZZ does not pay a dividend.How often does JAZZ pay dividends?
Over the last 12 months, JAZZ has issued dividend payments.JAZZ dividend forecast
Based on historical data, the forecasted dividends per share for JAZZ for the next 4 payments are between 0 (+0.0%) and 0 (+0.0%).This suggests the dividend will remain relatively stable.
Will JAZZ pay dividends in 2026?
The next Ex-Dividend date for Jazz Pharmaceuticals (JAZZ) is currently unknown.What is the next Ex-Dividend Date for JAZZ?
The next Ex-Dividend date for Jazz Pharmaceuticals (JAZZ) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.What is the Dividend Growth of JAZZ?
JAZZ's average dividend growth rate over the past 5 years is -% per year.
What is the Yield on Cost of JAZZ?
JAZZ's 5-Year Yield on Cost is -%. If you bought JAZZ's shares at 160.40 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.What is the Payout Consistency of JAZZ?
JAZZ Payout Consistency is 0.0%.
The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Does JAZZ have a good Dividend Yield?
JAZZ`s % Dividend Yield is considered as unknown.What is the Dividend Payout Ratio of JAZZ?
The Dividend Payout Ratio of JAZZ is unknown.What is the Dividend Rating of JAZZ?
JAZZ`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.Key Metric Definitions
- Dividend Yield: Annual dividend per share divided by current share price.
- Dividend Growth Rate: Compound annual growth rate of annual dividend per share over the last 5 years.
- Payout Ratio: Percentage of earnings paid as dividends (TTM).
- Payout Consistency: % of eligible periods with uninterrupted or increased dividends, measured over the entire lifetime of the stock or fund.
- Payout Frequency: Number of dividends paid in the last 12m (TTM).
- Overall Dividend Rating: Proprietary composite score, quantified on a scale from 0 to +100. Ratings surpassing 70 are regarded as favorable, while those exceeding 85 are strong.
- Total Return: Price appreciation plus dividends over specified period.
- Market Cap: Figures are in millions of the corresponding currency.
Last update: 2025-12-19 04:42